Thrombomodulin Expression in Bladder Cancer Tissue and Its Association with Prognosis and Patient Survival.
Joanne WattDaniel G MaguireCherith N ReidJohn V LamontStephen P FitzgeraldMark W RuddockPublished in: Research and reports in urology (2020)
TM immunoexpression in bladder cancer tissue may be a clinically relevant predictor of tumor progression and survival. Low expression of TM in bladder cancer biopsies or in recurrent bladder cancer may be indicative of a poor prognosis. TM immunoexpression could be used to guide clinical decision making.